Skip to content
    Font Size

    Rheumatoid Arthritis Drugs Are Underused

    Study Shows RA Drugs Known as DMARDs Aren’t Prescribed as Aggressively as They Should
    WebMD Health News
    Reviewed by Laura J. Martin, MD

    Feb. 1, 2011 -- Widely available drugs that are recommended early in the treatment of rheumatoid arthritis are not being prescribed nearly as much as they could be.

    That’s the conclusion of a new study that says effective medicines called disease-modifying antirheumatic drugs (DMARDs) are not being used as aggressively as called for under accepted medical guidelines.

    Researchers say that only 63% of Medicare patients reviewed for the study received any amount of the prescription medications.

    “Among patients with a true diagnosis of rheumatoid arthritis, closer to 90% should be receiving treatment,” study researcher Gabriela Schmajuk, MD, a postdoctoral scholar at Stanford, says in a news release.

    Schmajuk and colleagues, including Jinoos Yazdany, MD, MPH, of the University of California, San Francisco, report that the number of patients receiving the effective medications varies dramatically by health care plan, economic status, and where the patients live.

    Rheumatoid arthritis is a chronic, painful disease that leads to inflammation of the joints and tissues around the joints. RA is considered an autoimmune disease.

    The disease, which usually strikes people between the ages of 40 and 60, afflicts 1.3 million Americans, is three times more common in women than men.

    The Importance of DMARDs

    “The reason [DMARD] treatment is so important is that, if left untreated, one-third of the patients with rheumatoid arthritis will become disabled within five years of diagnosis,” Schmajuk says. “The disease primarily affects the hands. Frequently patients are unable to work because they can’t use their hands.”

    The large study examined differences in medication treatment of 93,143 people with rheumatoid arthritis ages 65 and older between the years 2005 and 2008. Information was obtained from the Healthcare Effectiveness Data and Information Set, also known as HEDIS.

    HEDIS, in 2005, introduced a quality measure to assess the number of RA patients receiving DMARDs.

    “We found that certain groups were not receiving the medication they needed,” Schmajuk says. “Patients who had low income received DMARDs less frequently than wealthier patients. Blacks received medications less frequently than whites. We also found that patients who lived in the mid-and south-Atlantic regions received medications less frequently than other areas, particularly the West Coast states.”

    Today on WebMD

    rubbing hands
    Avoid these 6 common mistakes.
    mature couple exercising
    Decrease pain, increase energy.
    mature woman threading needle
    How much do you know?
    Swelling, fatigue, pain, and more.
    honey bee
    Hand bones X-ray
    prescription pills
    Woman massaging her neck
    woman roasting vegetables in oven
    Woman rubbing shoulder
    doctor and patient hand examination